First, the mechanisms of IBD and its progression into CRC are not known, and adding another mechanistic layer, presumably Cox-2 inhibition by NSAIDs, only leads to more uncertainty regarding the question at hand. Here, PTGS2 is linked to inflammatory bowel disease.